Proliferation-dependent replication in primary macrophages of macrophage-tropic HIV type 1 variantsKOOTSTRA, N. A; SCHUITEMAKER, H.AIDS research and human retroviruses. 1998, Vol 14, Num 4, pp 339-345, issn 0889-2229Article

Molecular determinants of human immunodeficiency virus type I phenotype variabilityFOUCHIER, R. A. M; SCHUITEMAKER, H.European journal of clinical investigation. 1996, Vol 26, Num 3, pp 175-185, issn 0014-2972Article

T-cell dysfunction in HIV infection : anergy due to defective antigen-presenting cell function ?MEYAARD, L; SCHUITEMAKER, H; MIEDEMA, F et al.Immunology today (Amsterdam. Regular ed.). 1993, Vol 14, Num 4, pp 161-164, issn 0167-5699Article

Analysis of CD⁸⁺ T lymphocyte-mediated nonlytic suppression of autologous and heterologous primary human immunodeficiency virus type 1 isolatesKOOTSTRA, N. A; MIEDEMA, F; SCHUITEMAKER, H et al.AIDS research and human retroviruses. 1997, Vol 13, Num 8, pp 684-693, issn 0889-2229Article

Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosisKOOT, M; VAN LEEUWEN, R; DE GOEDE, R. E. Y et al.The Journal of infectious diseases. 1999, Vol 179, Num 1, pp 254-258, issn 0022-1899Article

No evidence for an effect of the CCR5 Δ32/+ and CCR2b 64I/+ mutations on human immunodeficiency virus (HGIV)-1 disease progression among HIV-1-infected injecting drug usersSCHINKEL, J; LANGENDAM, M. W; COUTINHO, R. A et al.The Journal of infectious diseases. 1999, Vol 179, Num 4, pp 825-831, issn 0022-1899Article

Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapyPRINS, J. M; JURRIAANS, S; DE WOLF, F et al.AIDS (London). 1999, Vol 13, Num 17, pp 2405-2410, issn 0269-9370Article

Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) studyREIJERS, M. H. E; WEVERLING, G. J; SCHUITEMAKER, H et al.Lancet (British edition). 1998, Vol 352, Num 9123, pp 185-190, issn 0140-6736Article

Envelope V2 configuration and HIV-1 phenotype : clarificationSCHUITEMAKER, H; FOUCHIER, R. A. M; BROERSEN, S et al.Science (Washington, D.C.). 1995, Vol 268, Num 5207, issn 0036-8075, p. 115Article

Recent development on research in AIDS pathogenesisSCHUITEMAKER, H; KOOT, M; MIEDEMA, F et al.Vox sanguinis (Basel. 1956). 1994, Vol 67, pp 133-136, issn 0042-9007, SUP3Conference Paper

Cis-diamminedichloroplatinum(II)-resistant sublines derived from two human ovarian tumor cell linesKUPPEN, P. J. K; SCHUITEMAKER, H; VAN'T VEER, L. J et al.Cancer research (Baltimore). 1988, Vol 48, Num 12, pp 3355-3359, issn 0008-5472Article

OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4 + T cell depletionVAN PRAAG, R. M. E; PRINS, J. M; FOX, C. H et al.Journal of clinical immunology. 2001, Vol 21, Num 3, pp 218-226, issn 0271-9142Article

Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort StudyMAAS, J. J. J; GANGE, S. J; SCHUITEMAKER, H et al.AIDS (London). 2000, Vol 14, Num 9, pp 1155-1161, issn 0269-9370Article

Normalization of the CD4 T cell receptor repertoire after evolution of syncytium-inducin HIV-1 variantsKOSTENSE, S; KROP, E; BLAAK, H et al.AIDS (London). 2000, Vol 14, Num 3, pp 330-331, issn 0269-9370Article

HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDSABEBE, A; DEMISSIE, D; GOUDSMIT, J et al.AIDS (London). 1999, Vol 13, Num 11, pp 1305-1311, issn 0269-9370Article

Presence of the variant mannose-binding lectin alleles associated with slower progression to AIDSMAAS, J; DE RODA HUSMAN, A.-M; BROUWER, M et al.AIDS (London). 1998, Vol 12, Num 17, pp 2275-2280, issn 0269-9370Article

Completion of nucleotide sequences of non-syncytium-inducing and syncytium-inducing HIV type 1 variants isolated from the same patientGUILLON, C; BEDIN, F; FOUCHIER, R. A. M et al.AIDS research and human retroviruses. 1995, Vol 11, Num 12, pp 1537-1538, issn 0889-2229Article

Effects of HIV-1 Tat protein on human T cell proliferationMEYAARD, L; OTTO, S. A; SCHUITEMAKER, H et al.European journal of immunology. 1992, Vol 22, Num 10, pp 2729-2732, issn 0014-2980Article

Reduced prevalence of the CCR5 Δ32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complexVAN RIJ, R. P; PORTEGIES, P; HALLABY, T et al.The Journal of infectious diseases. 1999, Vol 180, Num 3, pp 854-857, issn 0022-1899Article

Efficient inhibition of both syncytium-inducing and non-syncytium-inducing wild-type HIV-1 by lamivudine in vivoVAN'T WOUT, A. B; RAN, L. J; NIJHUIS, M et al.AIDS (London). 1998, Vol 12, Num 10, pp 1169-1176, issn 0269-9370Article

Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses : A predominant gag-specific response is associated with nonprogressive infectionPONTESILLI, O; KLEIN, M. R; KERKHOF-GARDE, S. R et al.The Journal of infectious diseases. 1998, Vol 178, Num 4, pp 1008-1018, issn 0022-1899Article

Potent inhibition of replication of primary HIV type 1 isolates in peripheral blood lymphocytes by negatively charged human serum albuminsGROENINK, M; SWART, P. J; BROERSEN, S et al.AIDS research and human retroviruses. 1997, Vol 13, Num 2, pp 179-185, issn 0889-2229Article

Association between CCR5 genotype and the clinical course of HIV-1 infectionDE RODA HUSMAN, A.-M; KOOT, M; COUTINHO, R. A et al.Annals of internal medicine. 1997, Vol 127, Num 10, pp 882-890, issn 0003-4819Article

Changes in cellular virus load and zidovudine resistance of syncytium-inducing and non-syncytium-inducing human immunodeficiency virus populations under zidovudine pressure : A clonal analysisVAN'T WOUT, A. B; DE JONG, M. D; KOOTSTRA, N. A et al.The Journal of infectious diseases. 1996, Vol 174, Num 4, pp 845-849, issn 0022-1899Article

IL4 and IL10 a potent inhibitors of HIV1 replication in macrophages in vitro : a role for cytokines in the in vivo virus host range ? CommentarySCHUITEMAKER, H; GRAZIOSI; GENDELMAN et al.Research in immunology (Paris). 1994, Vol 145, Num 8-9, pp 588-594, issn 0923-2494Article